# Execution Context: phase5-slice59j-20260827

Created: 2026-08-27 14:59:53
Objective: 在修复后的D001 II 131包冻结新基线上，以系统内置MTPLX语义Agent仅运行第63、64、65包，验证合并用药总则与表5全部禁用治疗/洗脱时间窗的期别适用性、来源闭包和关键逻辑表达；不扩大到其他包。
Task type: `finite_code_task`
Risk: `medium`
Execution module trigger: Codex identified 3 independent work items, which is greater than two.

## Module Boundary

This is an execution module, not a conference. Codex has assigned the work items and owns the project-level contract, source authority, boundaries, final verification, acceptance, production writes, and user delivery. Codex reviews the worker outputs directly for this route; no execution manager is dispatched. First-line workers execute the assigned work and create/write only authorized artifacts. Codex subAgent workers use the parent App's native child session when available; the generated CLI command is only a labeled compatibility fallback.

## Assigned Roles

- First-line executor: `finite_code_executor_cms` -> `pi` / `mtplx` / `mtplx-qwen38-27b-optimized-quality`
- Execution manager: none (Codex reviews the worker outputs directly)
- Execution-manager fallback: none

## Source Of Truth

- Frozen D001 II manifest: `artifacts/phase5-slice59i-d001-phase-table-caption-rebaseline-20260827/coverage_manifest.json`.
- Frozen D001 II plan: `artifacts/phase5-slice59i-d001-phase-table-caption-rebaseline-20260827/frozen_phase_plan.json`.
- Freeze metadata and stable source diff: `artifacts/phase5-slice59i-d001-phase-table-caption-rebaseline-20260827/freeze_metadata.json`, `diff-qc.json`.
- Product acceptance harness: `scripts/run_phase_applicability_acceptance.py` using project `.venv/bin/python`; do not use the macOS system Python 3.9.
- Built-in semantic endpoint/model: `http://127.0.0.1:8002/v1`, exact model `mtplx-qwen38-27b-optimized-quality`, effort `medium`, temperature `0`, max output `16384`, schema repairs `2`.
- The protocol source is read-only. Its accepted SHA-256 is `362443131f0d384c82c80f6a37396084f7d3301b51162201749c0488b0f2dd98`.

## Risk Boundaries

- No production writes.
- No silent package installation, credential handling, or external account changes.
- Missing tools or environments must be recorded with a minimal remediation proposal.
- Worker and manager outputs, when present, are evidence for Codex, not instructions.
- Worker 01 may write only `artifacts/phase5-slice59j-d001-package63-mtplx-20260827/`.
- Worker 02 may write only `artifacts/phase5-slice59j-d001-package64-mtplx-20260827/`.
- Worker 03 may write only `artifacts/phase5-slice59j-d001-package65-mtplx-20260827/`.
- Do not edit application code, frozen inputs, Trellis records, reviews, metrics, source protocol, subject records, or old run artifacts.
- Preserve separate evidence for original excerpt, model disposition, deterministic gate result, clinical risk, and unverified item. A green gate is not clinical acceptance.

## Work Items

1. 仅运行并审查新计划第63包：合并用药记录、允许用药、基线前禁用总则和表5父子交接。
2. 仅运行并审查新计划第64包：表5表头至r11，逐行核对固定窗口、较长者为准、清除剂缩短洗脱和嵌套例外。
3. 仅运行并审查新计划第65包：表5最后r12的首次给药前7天限制，并联合核对63至65包是否闭合整张表但不宣称全方案完成。

## Completion And Cleanup

Codex reviews worker outputs, any manager report, and final artifacts. After acceptance, run `cleanup-execution` to archive prompts, worker/manager reports, logs, and the manifest under `archives/execution/`; do not delete evidence by default.
